Soluble HLA-G in the peritoneal fluid of women with endometriosis

Fertility and Sterility

Volumn 89, Issue 2, 2008, Pages 465-467

  Eidukaite, Audrone ^a   Tamosiunas, Vytas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PERITONEAL FLUID; PRIORITY JOURNAL; RNA TRANSCRIPTION;

ADULT; ASCITIC FLUID; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LAPAROSCOPY; SOLUBILITY;

EID: 38949211096     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.02.036     Document Type: Article

References (28)

1. Oosterlynck D.J., Cornillie F.J., Waer M., Vandeputte M., and Koninckx P.R. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 56 (1991) 45-51
2. Oosterlynck D.J., Meuleman C., Waer M., Vandeputte M., and Koninckx P.R. The natural killer activity of peritoneal fluid lumphocytes is decreased in women with endometriosis. Fertil Steril 58 (1992) 290-295
3. Tanaka E., Sendo F., Kawagoe S., and Hirai M. Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 34 (1992) 2-30
4. Wilson T.J., Hertzog P.J., Angus D., Munnery L., Wood E.C., and Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 62 (1994) 1086-1088
5. Garzetti G.G., Cignitti M., Ciavattini A., Fabris N., and Romanini C. Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 34 (1992) 27-30
6. Vigano P., Gaffuri B., Somigliana E., Busacca M., Di Blasio A.M., and Vignali M. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 4 (1998) 1150-1156
7. Mazzeo D., Vigano P., Di Blasio A.M., Sinigaglia F., Vignali M., and Panina-Bordignon P. Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. J Clin Endocrinol Metabol 83 (1998) 911-916
8. Garcia-Velasco J.A., Mulayim N., Kayisli U.A., and Arici A. Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertil Steril 78 (2002) 855-859
9. Harada T., Kaponis A., Iwabe T., Taniguchi F., Makrydimas G., Sofikitis N., et al. Apoptosis in human endometrium and endometriosis. Hum Reprod Update 10 (2004) 29-38
10. Ungefroren H., Voss M., Jansen M., Roeder C., Henne-bruns D., Kremer B., et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 58 (1998) 1741-1749
11. Kauma S.W., Huff T.F., Hayes N., and Nilkaeo A. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metabol 84 (1999) 2188-2194
12. Starzinski-Powitz A., Handrow-Metzmacher H., and Kotzian S. The putative role of cell adhesion molecules in endometriosis; can we learn from tumour metastasis?. Mol Med Today 5 (1999) 304-309
13. Polakova K., and Russ G. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma 47 (2000) 342-348
14. Davies B., Hiby S., Gardner L., Loke Y.W., and King A. HLA-G expression by tumors. Am J Reprod Immunol 45 (2001) 103-107
15. Singer G., Kurman R.J., McMaster M., and Shih I.-M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 26 (2002) 914-920
16. Rebmann V., Regel J., Stolke D., and Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 13 (2003) 371-377
17. Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E.D., et al. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196 (2002) 266-274
18. Urosevic M., Willers J., Mueller B., Kempf W., Burg G., and Dummer R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99 (2002) 609-617
19. American Society for Reproductive Medicine. Revised classification of endometriosis. Fertil Steril 67 (1997) 817-821
20. Hornung D., Fujii E., Lim K.H., Vigne J.L., McMaster M.T., and Taylor R.N. Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 75 (2001) 814-817
21. Barrier B.F., Kendall B.S., Ryan C.E., and Sharpe-Timms K.L. HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod 21 (2006) 864-869
22. + cells by interacting with CD8. J Immunol 164 (2000) 6100-6104
23. Marchal-Bras Goncalves R., Rouas-Freiss N., Conna F., Choppin J., Dausset J., Carosella E.D., et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 33 (2001) 2355-2359
24. Kapasi K., Albert S.E., Yie M., Zavazavan N., and Libranch C.L. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101 (2000) 191-200
25. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., and Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166 (2001) 5018-5026
26. Bainbridge D., Ellis S.A., and Sargent I.L. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 48 (2000) 17-26
27. Kanai T., Fujii T., Unno N., Yamashita T., Hyodo H., Miki A., et al. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 45 (2001) 94-99
28. Matsuoka S., Maeda N., Izumiya C., Yamashita C., Nishimori Y., and Fukaya T. Expression of inhibitory-motif killer immunoglobulin-like receptor, KIR2DL1, is increased in natural killer cells from women with pelvic endometriosis. Am J Reprod Immunol 53 (2005) 249-254